• Advanced Oral Delivery: Maximizing Molecules, Targets, And Adherence

    Many patients continue to prefer the ease and convenience of orally administered medications and therapies. In this informative session on advances in oral drug delivery, expert panelists Jing Ling, Eduardo Jule, and Firouz Asgarzadeh will join host Tom von Gunden in a discussion of opportunities and challenges in designing oral delivery methods that a) expand...

    Free
  • Advancing Therapeutic Discovery With Reproducible High Throughput Electroporation

    As demand for advanced therapies continues to surge, the biopharma industry is under pressure to innovate faster in high-risk areas like drug discovery and cell therapy. These fields face persistent challenges, such as high costs, long development timelines, and complex regulatory landscapes. To that end, MaxCyte has introduced a new high-throughput electroporation platform that streamlines...

    Free
  • ABFO National Conference

    Philadelphia Philadelphia, PA, United States

    The ABFO National Conference is the leading event for Bioscience CFOs and senior finance professionals aspiring to be CFOs. Join us to gain insights from industry thought leaders and discover why attendees return year after year. Who should attend? CFOs: As the biotech landscape evolves at unprecedented speed, CFOs find themselves at the center of...

  • Simplifying ADC Analysis: Real-Time DAR and Concentration Measurement Without Dilution

    Online webinar

    Antibody-drug conjugates (ADCs) present unique analytical challenges, particularly in maintaining consistent drug-to-antibody ratio (DAR), minimizing variability, and reducing reliance on time-intensive off-line methods. These challenges are further compounded by the need to limit handling of highly potent payloads while maintaining process control. This webinar explores how variable pathlength spectroscopy enables rapid, accurate at-line and in-line...

  • Analytical Strategies for High-Volume GLP-1 Manufacturing

    Online webinar

    This presentation focuses on the analytical strategies required to enable high-volume production, including the deployment of high-throughput chromatographic methods for impurity profiling, integration of orthogonal techniques such as LC-MS for identity confirmation, and the role of stability-indicating methods in maintaining product quality.

  • BVS and BioMed Realty’s Biotech Community Event in SSF

    South San Francisco, CA CA, United States

    Join Us for the BVS and BioMed Realty Biotech Community Event! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. The vendor fair is held at The Forum, in the same building as Amgen and next to Genentech, right in...

  • The Art of Fundraising

    Online webinar

    Danforth Health provides the life sciences community with strategic and operational support across business, clinical and commercial functions. Moderated by: Barb Carlin, CPA, MBA, Managing Director, Mid Atlantic Region, Danforth Health  9:00 AM - 10:00 AM - Panel Discussion 10:00 AM - 10:30 AM - Networking in Zoom Breakout Rooms Questions? Contact Lauren Boyle, lboyle@lifesciencespa.org

  • Quality by Design: The Future of Automated Pharmaceutical Labeling

    Online webinar

    Pharmaceutical labeling continues to change and adapt to trends in product presentation & regulations. Considering trends in automation, product handling, and robotics, it is important to have standardized approaches to pharmaceutical labeling platforms. Rising trends in single use autoinjector devices and personalized medicines require quality design with the future in mind. Pharmaceutical labeling machines need...

    Free
  • Downstream Decisions To Maximize Vector Yields And Reduce COGs

    Online webinar

    Gene therapies are among the most expensive biopharmaceuticals to develop and manufacture, due in large part to persistent bottlenecks in downstream processing. When purification workflows lose 10% to 30% of vector at each unit operation, it forces developers to make critical tradeoffs to maximize yield without compromising product quality. Join Bioprocess Online on Thursday, May...

  • CAR-T Strategy in 2026: Scaling Autologous, Advancing Allogeneic

    Online webinar

    Join this thought leadership panel exploring how the CAR-T landscape continues to evolve as clinical and commercial experience grows. As autologous therapies expand into additional settings and allogeneic approaches continue to be studied, organizations are reassessing where to focus research, development, and operational efforts. This discussion brings together perspectives from across the cell therapy ecosystem...